Literature DB >> 33498483

Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment.

Théo Accogli1,2,3, Mélanie Bruchard1,2,3,4, Frédérique Végran1,2,3,4.   

Abstract

The advancement of knowledge on tumor biology over the past decades has demonstrated a close link between tumor cells and cells of the immune system. In this context, cytokines have a major role because they act as intermediaries in the communication into the tumor bed. Cytokines play an important role in the homeostasis of innate and adaptive immunity. In particular, they participate in the differentiation of CD4 T lymphocytes. These cells play essential functions in the anti-tumor immune response but can also be corrupted by tumors. The differentiation of naïve CD4 T cells depends on the cytokine environment in which they are activated. Additionally, at the tumor site, their activity can also be modulated according to the cytokines of the tumor microenvironment. Thus, polarized CD4 T lymphocytes can see their phenotype evolve, demonstrating functional plasticity. Knowledge of the impact of these cytokines on the functions of CD4 T cells is currently a source of innovation, for therapeutic purposes. In this review, we discuss the impact of the major cytokines present in tumors on CD4 T cells. In addition, we summarize the main therapeutic strategies that can modulate the CD4 response through their impact on cytokine production.

Entities:  

Keywords:  CD4; cancer; cytokines; immunotherapy

Year:  2021        PMID: 33498483      PMCID: PMC7864169          DOI: 10.3390/cancers13030373

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  196 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

3.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 4.  IL-2: the first effective immunotherapy for human cancer.

Authors:  Steven A Rosenberg
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

5.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

6.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

7.  The Interferon-Gamma Paradox in Cancer.

Authors:  M Raza Zaidi
Journal:  J Interferon Cytokine Res       Date:  2018-11-09       Impact factor: 2.607

8.  NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models.

Authors:  Deborah H Charych; Ute Hoch; John L Langowski; Steve R Lee; Murali K Addepalli; Peter B Kirk; Dawei Sheng; Xiaofeng Liu; Paul W Sims; Laurie A VanderVeen; Cherie F Ali; Thomas K Chang; Marina Konakova; Rhoneil L Pena; Rupesh S Kanhere; Yolanda M Kirksey; Chunmei Ji; Yujun Wang; Jicai Huang; Theresa D Sweeney; Seema S Kantak; Stephen K Doberstein
Journal:  Clin Cancer Res       Date:  2016-02-01       Impact factor: 12.531

9.  IL-2 regulates expression of C-MAF in human CD4 T cells.

Authors:  Aradhana Rani; Behdad Afzali; Audrey Kelly; Lemlem Tewolde-Berhan; Mark Hackett; Aditi S Kanhere; Isabela Pedroza-Pacheco; Holly Bowen; Stipo Jurcevic; Richard G Jenner; David J Cousins; Jack A Ragheb; Paul Lavender; Susan John
Journal:  J Immunol       Date:  2011-08-29       Impact factor: 5.422

10.  The role of interleukin-17 in tumor development and progression.

Authors:  Junjie Zhao; Xing Chen; Tomasz Herjan; Xiaoxia Li
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more
  6 in total

Review 1.  Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma.

Authors:  Feng Tang; Zhiyong Pan; Yi Wang; Tian Lan; Mengyue Wang; Fengping Li; Wei Quan; Zhenyuan Liu; Zefen Wang; Zhiqiang Li
Journal:  Neurosci Bull       Date:  2022-06-07       Impact factor: 5.271

2.  Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells.

Authors:  Maria Isaguliants; Olga Krotova; Stefan Petkov; Juris Jansons; Ekaterina Bayurova; Dzeina Mezale; Ilze Fridrihsone; Athina Kilpelainen; Philip Podschwadt; Yulia Agapkina; Olga Smirnova; Linda Kostic; Mina Saleem; Oleg Latyshev; Olesja Eliseeva; Anastasia Malkova; Tatiana Gorodnicheva; Britta Wahren; Ilya Gordeychuk; Elizaveta Starodubova; Anastasia Latanova
Journal:  Microorganisms       Date:  2021-06-04

Review 3.  Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment.

Authors:  Nagaja Capitani; Laura Patrussi; Cosima T Baldari
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

4.  INSC Is a Prognosis-Associated Biomarker Involved in Tumor Immune Infiltration in Colon Adenocarcinoma.

Authors:  Su Zhaoran; Jia Weidong
Journal:  Biomed Res Int       Date:  2022-09-12       Impact factor: 3.246

5.  Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder.

Authors:  Miguel Angel Alvarez-Mon; Ana Maria Gómez-Lahoz; Arancha Orozco; Guillermo Lahera; David Diaz; Miguel A Ortega; Agustin Albillos; Javier Quintero; Enrique Aubá; Jorge Monserrat; Melchor Alvarez-Mon
Journal:  J Pers Med       Date:  2021-03-19

6.  Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells.

Authors:  Bjoern Traenkle; Philipp D Kaiser; Stefania Pezzana; Jennifer Richardson; Marius Gramlich; Teresa R Wagner; Dominik Seyfried; Melissa Weldle; Stefanie Holz; Yana Parfyonova; Stefan Nueske; Armin M Scholz; Anne Zeck; Meike Jakobi; Nicole Schneiderhan-Marra; Martin Schaller; Andreas Maurer; Cécile Gouttefangeas; Manfred Kneilling; Bernd J Pichler; Dominik Sonanini; Ulrich Rothbauer
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.